Abstract
Understanding compound-driven cell toxicity is vitally important for all drug discovery approaches. With high-throughput screening (HTS) being the key strategy to find hit and lead compounds for drug discovery projects in the pharmaceutical industry [1], an understanding of the cell toxicity profile of hit molecules from HTS activities is fundamentally important. Recently, there has been a resurgence of interest in phenotypic drug discovery and these cell-based assays are now being run in HTS labs on ever increasing numbers of compounds. As the use of cell assays increases the ability to measure toxicity of compounds on a large scale becomes increasingly important to ensure that false hits are not progressed and that compounds do not carry forward a toxic liability that may cause them to fail at later stages of a project. Here we describe methods employed in the AstraZeneca HTS laboratory to carry out very large scale cell toxicity screening.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Macarron R et al (2011) Impact of high-throughput screening in biomedical research. Nat Rev Drug Discov 10:188–195
Mayr LM, Bojanic D (2009) Novel trends in high-throughput screening. Curr Opin Pharmacol 9:580–588
Cook D et al (2014) Lessons learned from the fate of AstraZeneca’s drug pipeline: a five-dimensional framework. Nat Rev Drug Discov 13:419–431
O’Brien J et al (2000) Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267:5421–5426
Hamid R et al (2004) Comparison of alamar blue and MTT assays for high through-put screening. Toxicol In Vitro 18(2004):703–710
Nakayama GR et al (1997) Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J Immunol Methods 204:205–208
Slater K (2001) Cytotoxicity tests for high-throughput drug discovery. Curr Opin Biotechnol 12:70–74
Weyermann J et al (2005) A practical note on the use of cytotoxicity assays. Int J Pharm 288:369–376
Promega Corporation. CellToxâ„¢ Green Cytotoxicity Assay. https://www.promega.com/products/cell-health-and-metabolism/cytotoxicity-assays/real-time-cytotoxicity-assay/celltox-green-cytotoxicity-assay/?activeTab= 0. Accessed 1 July 2015
McDougal M et al (2010) Nucleic acid binding dyes and uses thereof. US Patent 2010/0233710 A1
Korzeniewski C, Callewaert DM (1983) An enzyme-release assay for natural cytotoxicity. J Immunol Methods 64:313–320
Lobner D (2000) Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis? J Neurosci Methods 96:147–152
Fotakis G, Timbrell JA (2006) In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett 160:171–177
Luu YK et al (2012) Profiling of toxicity and identification of distinct apoptosis profiles using a 384-well high-throughput flow cytometry screening platform. J Biomol Screen 17:806–812
Griffith D et al (2012) Implementation and development of an automated, ultra-high-capacity, acoustic, flexible dispensing platform for assay-ready plate delivery. J Lab Autom 17(5):348–358
Zhang J-H et al (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4:67–73
Lundholt BK et al (2003) A simple technique for reducing edge effect in cell-based assays. J Biomol Screen 8:566–570
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Murray, D., McWilliams, L., Wigglesworth, M. (2016). High-Throughput Cell Toxicity Assays. In: Janzen, W. (eds) High Throughput Screening. Methods in Molecular Biology, vol 1439. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3673-1_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3673-1_16
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3671-7
Online ISBN: 978-1-4939-3673-1
eBook Packages: Springer Protocols